These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36550158)

  • 21. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 22. ERK1/2 Phosphorylation of FHOD Connects Signaling and Nuclear Positioning Alternations in Cardiac Laminopathy.
    Antoku S; Wu W; Joseph LC; Morrow JP; Worman HJ; Gundersen GG
    Dev Cell; 2019 Dec; 51(5):602-616.e12. PubMed ID: 31794718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of cytoskeleton in cardiomyopathy caused by mutations in
    Chatzifrangkeskou M; Le Dour C; Muchir A
    Am J Physiol Cell Physiol; 2023 Jun; 324(6):C1223-C1235. PubMed ID: 37125775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.
    Auguste G; Rouhi L; Matkovich SJ; Coarfa C; Robertson MJ; Czernuszewicz G; Gurha P; Marian AJ
    J Clin Invest; 2020 Sep; 130(9):4740-4758. PubMed ID: 32484798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
    Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
    Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects.
    Gerbino A; Bottillo I; Milano S; Lipari M; Zio R; Morlino S; Mola MG; Procino G; Re F; Zachara E; Grammatico P; Svelto M; Carmosino M
    Cell Physiol Biochem; 2017; 44(4):1559-1577. PubMed ID: 29197877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice.
    Wu W; Jin Q; Östlund C; Tanji K; Shin JY; Han J; Leu CS; Kushner J; Worman HJ
    Circ Heart Fail; 2024 Apr; 17(4):e011110. PubMed ID: 38567527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of autophagy ameliorates LMNA cardiomyopathy.
    Choi JC; Worman HJ
    Autophagy; 2013 Jan; 9(1):110-1. PubMed ID: 23044536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connexin 43 remodeling induced by LMNA gene mutation Glu82Lys in familial dilated cardiomyopathy with atrial ventricular block.
    Sun LP; Wang L; Wang H; Zhang YH; Pu JL
    Chin Med J (Engl); 2010 Apr; 123(8):1058-62. PubMed ID: 20497714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.
    Xiong Y; Bedi K; Berritt S; Attipoe BK; Brooks TG; Wang K; Margulies KB; Field J
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30762586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.
    Broers JL; Peeters EA; Kuijpers HJ; Endert J; Bouten CV; Oomens CW; Baaijens FP; Ramaekers FC
    Hum Mol Genet; 2004 Nov; 13(21):2567-80. PubMed ID: 15367494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cypher/ZASP drives cardiomyocyte maturation via actin-mediated MRTFA-SRF signalling.
    Lyu J; Pan Z; Li R; Yu H; Zhang Y; Wang D; Yin X; He Y; Zhao L; Chen S; Zhang S; Cheng H; Guo X
    Theranostics; 2024; 14(11):4462-4480. PubMed ID: 39113806
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevated MTORC1 signaling and impaired autophagy.
    Ramos FJ; Kaeberlein M; Kennedy BK
    Autophagy; 2013 Jan; 9(1):108-9. PubMed ID: 23064282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LMNA E82K mutation activates FAS and mitochondrial pathways of apoptosis in heart tissue specific transgenic mice.
    Lu D; Lian H; Zhang X; Shao H; Huang L; Qin C; Zhang L
    PLoS One; 2010 Dec; 5(12):e15167. PubMed ID: 21151901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene.
    Wu W; Shan J; Bonne G; Worman HJ; Muchir A
    Biochim Biophys Acta; 2010; 1802(7-8):632-8. PubMed ID: 20388542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.